These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13786857)

  • 1. [Effect of 2-(p-aminophenyl)-N-(alpha-methylphenethyl)-acetamide (IEM-366) on the central nervous system and its antagonistic relationship with phenamine].
    WU H; BAIBEKOV EB
    Farmakol Toksikol; 1961; 24():22-30. PubMed ID: 13786857
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of physostigmine and amphetamine in antagonizing the EEG effects of CNS depressants.
    WHITE RP; BOYAJY LD
    Proc Soc Exp Biol Med; 1959 Nov; 102():479-83. PubMed ID: 13844396
    [No Abstract]   [Full Text] [Related]  

  • 3. 6-Aminonicotinamide, a central nervous system depressant.
    REDETZKI HM; ALVAREZ-O'BOURKE F
    J Pharmacol Exp Ther; 1962 Aug; 137():173-8. PubMed ID: 14490930
    [No Abstract]   [Full Text] [Related]  

  • 4. STRUCTURE-ACTIVITY RELATIONSHIP IN THE PHENYLISOPROPYLAMINE GROUP. V. THE ACTION OF DL-M AND P-DI-(2-AMINOPROPYL)-BENZENES ON THE CENTRAL NERVOUS SYSTEM.
    WOJEWODZKI W
    Arch Immunol Ther Exp (Warsz); 1964; 12():602-10. PubMed ID: 14252041
    [No Abstract]   [Full Text] [Related]  

  • 5. A new series of central depressants: N-alkylaryl camphidines.
    HERMANSEN K
    Acta Pharmacol Toxicol (Copenh); 1960; 17():277-87. PubMed ID: 13713638
    [No Abstract]   [Full Text] [Related]  

  • 6. The inhibition of amine oxidase and the central stimulating action of the stereoisomeric amphetamines and 1-phenylethylamines.
    GRANA E; LILLA L
    Br J Pharmacol Chemother; 1959 Dec; 14(4):501-4. PubMed ID: 13828860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CENTRAL NERVOUS SYSTEM DEPRESSANT ACTIVITY OF MA1337, 3-(3-(4-M-CHLOROPHENYL-1-PIPERAZYL)PROPYL)-2,4(1H,3H)QUINAZOLINEDIONE HYDROCHLORIDE.
    FUJIMORI H; COBB DP
    J Pharmacol Exp Ther; 1965 May; 148():151-7. PubMed ID: 14302151
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of various pharmacodynamic agents on the penetration of amphetamine into the central nervous system of the rat].
    DRESSE A; CESSION-FOSSION A
    Arch Int Pharmacodyn Ther; 1962 Feb; 135():485-8. PubMed ID: 13887790
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological characteristic of the product of condensation of phenamine with gamma-aminobutyric acid].
    Aleksandrova AE; Smirnova SM
    Farmakol Toksikol; 1968; 31(5):525-6. PubMed ID: 5707719
    [No Abstract]   [Full Text] [Related]  

  • 10. [The specific effect of chloralose on recurrent inhibition of tonic motor neurons].
    HAASE J; van der MEULEN J
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1961; 274():272-80. PubMed ID: 13903366
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative psychopharmacology of haloperidol and of its derivatives (triperidol, methylperidide, "R 1647")].
    COLLARD J
    Rev Can Biol; 1961 Jun; 20():465-73. PubMed ID: 13880513
    [No Abstract]   [Full Text] [Related]  

  • 12. [DO NEUROTROPIC FLUORESCENT AGENTS ACT UPON THE CENTRAL NERVOUS SYSTEM?].
    FOUSSARD-BLANPIN O; BRETAUDEAU J
    C R Seances Soc Biol Fil; 1964; 158():1931-4. PubMed ID: 14262542
    [No Abstract]   [Full Text] [Related]  

  • 13. [EXPERIMENTAL CHRONAXIMETRIC STUDY OF SEVERAL PSYCHOTROPIC AGENTS AND OF THEIR ACTION ON THE NERVOUS EFFECTS OF ETHYL ALCOHOL. 3. PSYCHOTONIC AND PSYCHODYSLEPTIC AGENTS].
    LECOQ R; CHAUCHARD P; MAZOUE H
    Therapie; 1964; 19():983-9. PubMed ID: 14190955
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the central effect of phenmetrazine, dexphenmetrazine and psychoton after a single injection in normal volunteers].
    VOJTECHOVSKY M; HORACKOVA E
    Act Nerv Super (Praha); 1961 May; 3():203-5. PubMed ID: 13926534
    [No Abstract]   [Full Text] [Related]  

  • 15. [The development, course and outcome of experimental tetanus intoxication in conditions of changed functional condition of the central nervous system].
    SADOVSKAIA VT
    Biull Eksp Biol Med; 1960 Mar; 49():41-6. PubMed ID: 14440702
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the pharmacodynamics of a new neuroleptic: the alpha-isomer of 2-chloro-9-(3-dimethylaminopropylidene)-thiaxanthene HC1 or tractan. Action on the sleep centers, on motor excitation caused by nikethamide, on pentylenetetrazole, electroshock and psychomotor excitation due to amphetamine].
    FROMMEL E; FLEURY C; BEGUIN M
    C R Seances Soc Biol Fil; 1960; 154():1182-5. PubMed ID: 24545620
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preliminary contribution to the application of a psychopharmacological method of differential diagnostic evaluation of depression].
    GIBERTI F; ROSSI R; BATTISTELLA G
    Riv Sper Freniatr Med Leg Alien Ment; 1961 Dec; 85():1193-211. PubMed ID: 13898383
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of amphetamine and its derivatives on central nervous function].
    SOEHRING K; ERGENZINGER G
    Arzneimittelforschung; 1955 Aug; 5(8):478-83. PubMed ID: 13276258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of central analeptics in acute hypnotic poisoning].
    RIISHEDE J
    Ugeskr Laeger; 1950 May; 112(19):684-6. PubMed ID: 15443097
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relations between function and metabolism of the central nervous system after pervitin administration].
    HEIM F; LEUSCHNER F; ESTLER KJ
    Experientia; 1957 Nov; 13(11):462-4. PubMed ID: 13501230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.